Twitter Beğeni Hilesi

Very excited to share our latest publication for identification of tetracyclines as therapeutic solution for neuropathic pain. It was really good to work with Hesham Sadek and Enas Kandil. pnas.org/content/118/10…

Decision Making is an art by itself pubs.acs.org/doi/10.1021/ac…

Molecular simulations unravel the role of loop dynamics in regulating catalysis by protein tyrosine phosphatases. An investigation by Caroline Lynn Kamerlin 🇺🇸🇬🇧🇸🇪🇮🇷 ☀️ 🇪🇺🦓, [email protected] and coworkers acspubs.co/UkRA50DTue7

In this issue: Wine trade in medieval Islamic Sicily, tetracycline combinations inhibit neuropathic pain in mice, and how giant unicellular slime molds encode memories. ow.ly/WozZ50DVazE

We got featured at the cover. Tetracycline combinations for neuropathic pain. Hesham Sadek

Fantastic visit with Mayor Eric Adams in my lab at @columbia to discuss our NYCEDC -funded Therapeutic Validation Center. Thank you Mr. Mayor for supporting #science building the life science ecosystem, and helping us create #Jobs for New Yorkers!

⁦Sarafan ChEM-H⁩ is excited to welcome Mischel Lab⁩ just in time to celebrate this groundbreaking work posted ⁦bioRxiv⁩, collaboration with Cravatt lab. Discovered SMPD1 as a target for GBM, potently inhibited by fluoxetine! biorxiv.org/content/10.110…

Two drugs are better than one—blocking drug action in the periphery while maintaining CNS pharmacology (mTOR, Lrrk2 and Her2). #Glioblastoma Ziyang Zhang and Waweisslab.UCSF.edu UCSF Helen Diller Family Comprehensive Cancer Ctr HHMI College of Chemistry michaeljfox.org nature.com/articles/s4158…

Really happy to see it out. The first structural corrector for genetic cardiomyopathy. Stay tuned for more stories.

1/ Grant-writing tips. This #tweetorial mainly applies to NIH grants (particularly R01s) but some stuff may be applicable to other types of grants and funding agencies. Based on my experience writing grants for 20 yrs +lots of cringe-worthy missteps and rejections along the way!

💯 '‘the rule of two’: At least two chemical probes (either orthogonal target-engaging probes, and/or a pair of a chemical probe and matched target-inactive compound) to be employed at recommended concentrations in every study.' nature.com/articles/s4146…

Such a huge loss :( الله يرحمه و يحسن اليه cen.acs.org/people/obituar… via C&EN (Chemical & Engineering News)

Excited to share our recent work where we identify two FDA-approved drugs that induce heart regeneration in small and large animals. Outstanding work by Mahmoud Salama Ahmed and Nguyen Ngoc Uyen Nhi! Bringing regenerative therapies a step closer to the clinic rdcu.be/dANtR

What if you could carve your own pathway to a rewarding career in pharmacy? At TTUHSC Jerry H. Hodge School of Pharmacy, we are excited to introduce the Pioneer Pathway, a groundbreaking flexible approach to high-quality clinical pharmacy education that will start in Fall 2024. dailydose.ttuhsc.edu/2024/march/sop…

We are seeking to fill two postdoctoral fellows in synthetic medicinal chemistry. Projects aim to develop novel opioid modulators using structure-based design in collaboration with the Jay Mclaughlin lab at UF and Brian Kobilka lab at Stanford. Email me [email protected]

We're still looking for a motivated postdoc to help us investigate the role of bacterial biofilms in IBD. Pls RT Apply through this link: apps.ualberta.ca/careers/postin…